arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

ProMIS Neurosciences Inc.

PMN

$13.50 ▲ +0.02 (+0.15%) at close

22 Visible periods

22 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, ProMIS Neurosciences Inc. shows solid but mixed fundamentals, with Return on Invested Capital holding up well. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $88.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -11.2% ↘

FCF / Share $-1.90

Trailing P/E —

Price / Book 2.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-8.24M

↓ -12.2% —

FCF / Share Free cash flow per share

$-1.90

↑ +46.3% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 2521.2% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.71x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
EPS Growth YoY (%)	76.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-123.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-10.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	51.9% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	67.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	90.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	77.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-264.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-325.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-533.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-12.2% Weak ↑ Weak Improving Year-over-year change in net income	-4381.0% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-285.6% Weak ↓ Weak Declining Year-over-year change in net income	-102.1% Weak ↓ Weak Declining Year-over-year change in net income	93.3% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-13.5% Weak ↓ Weak Declining Year-over-year change in net income	26.7% Excellent ↓ Excellent Declining Year-over-year change in net income	50.7% Excellent ↑ Excellent Improving Year-over-year change in net income	60.4% Excellent ↑ Excellent Improving Year-over-year change in net income	15.8% Good ↑ Good Improving Year-over-year change in net income	-136.7% Weak ↑ Weak Improving Year-over-year change in net income	-223.7% Weak ↑ Weak Improving Year-over-year change in net income	-392.0% Weak Weak Year-over-year change in net income	-1117.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	46.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	73.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-76.4% Weak Weak Year-over-year change in free cash flow	—	—	—	36.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
FCF / Net Income (x)	1.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	36.59x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	2.83x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.52x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.61x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	1.81x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	2.50x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-11.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	676.2% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	-101.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2103.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	94.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-3767.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	26.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	63.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	499.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-655.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-83.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	12.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-12.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-117.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-107.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-192.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-103.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-193.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-112.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-123.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-112.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-25.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-13.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	—	-126.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-940%)	—	-77.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-617%)	-1.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-110%)	127.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+750%)	115.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+668%)	—	-95.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-736%)	-34.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	27.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+81%)	80.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+435%)	—	—	-40.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	-56.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-474%)	-39.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-364%)	-15.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.69x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+15%)	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	-4434677.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2713706.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-47.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-36.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.65x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-14.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-63.81M	$-6.12M	$-15.40M	$-4.51M	$-8.36M	$-13.29M	$-21.54M	$-992.46K	$-2.50M	$-12.60M	$-16.87M	$-1.22M	$-3.33M	$-5.88M	$-3.92M	$-8.90M	—	$-13.04M	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.86x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Basic EPS, GAAP (USD)	$-1.26	$-21.83	$-6.00	$-7.25	$-5.25	$2.55	$7.75	$-3.25	$-4.75	$-2.25	$-4.75	$-6.75	$-14.50	$-22.75	$-21.25	$-9.50	$-7.25	$-6.25	$-5.00	$-1.50	—	—
Free Cash Flow per Share (USD)	$-1.90	—	$-5.15	$-2.76	$-3.53	—	—	—	$-13.17	—	—	—	$-7.46	—	—	—	$-11.70	—	$-12.80	—	—	—
Book Value per Share (USD)	$6.77	$-0.58	$4.27	$-0.29	$7.24	$12.61	$5.56	$-3.00	$0.10	$4.97	$9.12	$-24.85	$-18.01	$-3.93	$2.54	$23.31	$12.99	$19.67	$33.03	$-34.66	—	—
Tangible Book Value per Share (USD)	$6.77	$-0.58	$4.27	$-0.29	$7.24	$12.61	$5.56	$-3.00	$0.10	$4.97	$9.09	$-24.91	$-18.06	$-3.99	$2.46	$23.23	$12.99	$19.57	$33.03	$-34.66	—	—
Basic Weighted Avg Shares (shares)	6.53M	—	1.95M	1.39M	1.39M	—	1.20M	790,830	781,359	—	494,833	343,171	343,171	—	287,821	287,821	287,821	—	236,779	203,967	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$59.00M	$-1.23M	$9.25M	$-314.59K	$9.59M	$16.69M	$21.88M	$-1.76M	$902.39K	$4.27M	$8.01M	$-7.26M	$-4.30M	$490.44K	$2.26M	$8.29M	—	$16.79M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$3.91M	—	—	—	—
Total Equity (USD)	$60.72M	$-1.26M	$9.19M	$-382.58K	$9.47M	$16.49M	$7.27M	$-2.28M	$77.10K	$3.75M	$6.75M	$-8.53M	$-6.18M	$-1.35M	$729.76K	$6.71M	$3.74M	$5.66M	$7.82M	$-7.07M	$-796.66K	$-796.66K

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Depreciation Expense (USD)	—	—	—	—	—	—	—	—	—	$-1.00	—	—	$322.00	$373.00	$1.88K	$2.11K	$1.78K	$8.24K	$10.86K	$10.75K	—	—
Net Income, GAAP (USD)	$-8.24M	$-10.67M	$-11.58M	$-10.12M	$-7.35M	$-238.21K	$9.28M	$-2.62M	$-3.64M	$-3.58M	$-2.36M	$-2.31M	$-4.96M	$-7.27M	$-5.96M	$-2.75M	$-2.09M	$-2.24M	$-1.21M	$-225.54K	—	—
Operating Cash Flow (USD)	$-12.38M	$-9.28M	$-10.06M	$-3.85M	$-4.93M	$-8.72M	—	—	$-10.29M	$-3.76M	—	—	$-2.56M	$-4.55M	—	—	$-3.37M	$-4.05M	$-3.03M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

ProMIS Neurosciences Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare PMN with peers